CIK: 1191039 - Address: Scolr Pharma, Inc., 19204 N. Creek Parkway, Suite 100, Bothell, WA 98011
6 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

P%ret1121-10-314893
P%wins1000501005010067

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y

1/25/08 19:40
1/22/08
DDDScolr Pharma, Inc.DEHealthDiagnIn Vitro & In Vivo DiagnosticLucas Herbert L JrWADM.d201.005203712D-25-12-30-32-14031311128-17-55
3/19/07 16:44
3/19/07
DDDScolr Pharma, Inc.DEHealthDiagnIn Vitro & In Vivo DiagnosticLucas Herbert L JrWADM.d60.32004203692D1-22226-8-7-7-329133020-25
11/8/06 14:23
11/7/06
DDDScolr Pharma, Inc.DEHealthDiagnIn Vitro & In Vivo DiagnosticLucas Herbert L JrWADM.d120.80004152672D-6-16-371-24-14-14-9462324624
4/21/06 13:37
4/19/06
DDDScolr Pharma, Inc.DEHealthDiagnIn Vitro & In Vivo DiagnosticLucas Herbert L JrWADM.d540.900026011625-15-8-27-26-14
4/11/05 12:46
4/7/05
DDDScolr Pharma, Inc.DEHealthDiagnIn Vitro & In Vivo DiagnosticLucas Herbert L JrWADP583.853153565D282839247151051-14-2310-70
3/9/05 14:28
3/7/05
DDDScolr Pharma, Inc.DEHealthDiagnIn Vitro & In Vivo DiagnosticLucas Herbert L JrWADP.d180.90003204550D15947638-15-15-8-31-617172217

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact